NASDAQ:MRVI
Maravai LifeSciences Holdings, Inc.
- Stock
Last Close
9.21
30/08 20:00
Market Cap
1.03B
Beta: −0.23
Volume Today
1.14M
Avg: 1.43M
PE Ratio
9.61
PFCF: 8.22
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -16.91M - | -5.20M 69.25% | 78.82M 1,615.40% | 469.25M 495.37% | 490.66M 4.56% | -119.03M 124.26% | |
depreciation and amortization | 22.35M - | 24.08M 7.77% | 25.84M 7.28% | 24.75M 4.20% | 38.10M 53.94% | 48.78M 28.02% | |
deferred income tax | 317K - | -1.16M 465.62% | -5.46M 371.44% | 46.90M 958.42% | 42.32M 9.78% | 754.94M 1,683.97% | |
stock based compensation | 2.12M - | 1.68M 20.84% | 24.63M 1,366.89% | 10.46M 57.54% | 18.67M 78.52% | 34.59M 85.26% | |
change in working capital | -15.84M - | 2.29M 114.46% | 35.89M 1,467.38% | -176.63M 592.10% | -45.08M 74.48% | 97.84M 317.04% | |
accounts receivables | -4.15M - | -1.89M 54.46% | -33.14M 1,655.51% | -70.39M 112.38% | -22.27M 68.36% | 84.39M 478.93% | |
inventory | 2.31M - | 106K 95.41% | -19.10M 18,117.92% | -21.57M 12.96% | 9.46M 143.84% | 649K 93.14% | |
accounts payables | -871K - | 2.47M 383.58% | 1.18M 52.39% | 676K 42.52% | -1.58M 333.43% | 5.28M 434.85% | |
other working capital | -13.13M - | 1.60M 112.20% | 86.96M 5,328.21% | -85.34M 198.14% | -30.69M 64.04% | 7.52M 124.49% | |
other non cash items | 7.79M - | 2.42M 68.89% | -7.52M 410.65% | -6.16M 18.09% | -8.70M 41.08% | -690.90M 7,845.97% | |
net cash provided by operating activities | -186K - | 24.11M 13,065.05% | 152.19M 531.09% | 368.57M 142.18% | 535.98M 45.42% | 126.22M 76.45% | |
investments in property plant and equipment | -3.61M - | -17.15M 374.88% | -25.41M 48.17% | -14.85M 41.55% | -17.09M 15.08% | -65.55M 283.58% | |
acquisitions net | 160K - | -3.02M - | 119.96M 4,066.83% | -238.35M 298.70% | -69.62M 70.79% | ||
purchases of investments | |||||||
sales maturities of investments | |||||||
other investing activites | 34.50M - | 548K 98.41% | -12.17M 2,321.35% | 12.87M 205.68% | |||
net cash used for investing activites | -3.45M - | -17.15M 396.90% | 6.07M 135.39% | 105.66M 1,641.18% | -267.61M 353.29% | -122.31M 54.30% | |
debt repayment | -255.20M - | -2.64M 98.97% | -412.08M 15,508.94% | -6M 98.54% | -13.89M 131.58% | -5.77M 58.46% | |
common stock issued | 1.76B - | 1.71M 99.90% | 2.36M 37.98% | -20K 100.85% | |||
common stock repurchased | -227K - | -1.46B 642,182.82% | |||||
dividends paid | -52.06M - | -609.32M - | |||||
other financing activites | 298.09M - | -1.30M 100.44% | 773.66M 59,612.23% | -154.76M 120.00% | -175.96M 13.70% | -55.30M 68.57% | |
net cash used provided by financing activities | -9.17M - | -4.17M 54.54% | 53.21M 1,376.99% | -159.05M 398.90% | -187.50M 17.89% | -61.09M 67.42% | |
effect of forex changes on cash | -69K - | 34K 149.28% | 17K 50% | -88K 617.65% | 1.61M - | ||
net change in cash | -12.87M - | 2.83M 122.02% | 211.48M 7,362.39% | 315.09M 48.99% | 80.87M 74.34% | -57.18M 170.70% | |
cash at beginning of period | 34.74M - | 21.87M 37.06% | 24.70M 12.96% | 236.18M 856.21% | 551.27M 133.41% | 632.14M 14.67% | |
cash at end of period | 21.87M - | 24.70M 12.96% | 236.18M 856.21% | 551.27M 133.41% | 632.14M 14.67% | 574.96M 9.04% | |
operating cash flow | -186K - | 24.11M 13,065.05% | 152.19M 531.09% | 368.57M 142.18% | 535.98M 45.42% | 126.22M 76.45% | |
capital expenditure | -3.61M - | -17.15M 374.88% | -25.41M 48.17% | -14.85M 41.55% | -17.09M 15.08% | -65.55M 283.58% | |
free cash flow | -3.80M - | 6.97M 283.49% | 126.78M 1,719.71% | 353.72M 179.01% | 518.89M 46.69% | 60.67M 88.31% |
All numbers in USD (except ratios and percentages)